TRICYCLIC PYRIDAZINE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

摘要

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I) where Ar, p, J, K, L, Q, W, V, R³, R⁴ and R⁵ are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.